These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Mathematical models of pharmacokinetics in chemotherapy]. Soloviev V; Fishman VM; Firsov AA Pharmazie; 1976; 31(12):825-39. PubMed ID: 799315 [No Abstract] [Full Text] [Related]
3. Prediction of the distribution of methotrexate in the sting rays Dasyatidae sabrina and sayi by use of a model developed in mice. Zaharko DS; Dedrick RL; Oliverio VT Comp Biochem Physiol A Comp Physiol; 1972 May; 42(1):183-94. PubMed ID: 4402707 [No Abstract] [Full Text] [Related]
5. The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys. Henderson ES; Adamson RH; Denham C; Oliverio VT Cancer Res; 1965 Aug; 25(7):1008-17. PubMed ID: 4954195 [No Abstract] [Full Text] [Related]
6. Transport and binding of methotrexate in vivo. Dedrick RL; Zaharko DS; Lutz RJ J Pharm Sci; 1973 Jun; 62(6):882-90. PubMed ID: 4712617 [No Abstract] [Full Text] [Related]
8. Improved methotrexate therapy of murine tumors obtained by probenecid-mediated pharmacological modulation at the level of membrane transport. Sirotnak FM; Moccio DM; Hancock CH; Young CW Cancer Res; 1981 Oct; 41(10):3944-9. PubMed ID: 7285003 [No Abstract] [Full Text] [Related]
9. Pharmacokinetics and organ distribution of methotrexate in the rat. Scheufler E; Zetler G; Iven H Pharmacology; 1981; 23(2):75-81. PubMed ID: 7312939 [TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of methotrexate in psoriasis therapy. Hendel J Dan Med Bull; 1985 Dec; 32(6):329-37. PubMed ID: 3908004 [No Abstract] [Full Text] [Related]
11. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene. Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194 [TBL] [Abstract][Full Text] [Related]
13. Tissue distribution of folate antagonists. Oliverio VT; Zaharko DS Ann N Y Acad Sci; 1971 Nov; 186():387-99. PubMed ID: 4943809 [No Abstract] [Full Text] [Related]
14. Pharmacokinetic model for 2-amino-1,3,4-thiadiazole in mouse, dog, and monkey. King FG; Dedrick RL Cancer Treat Rep; 1979; 63(11-12):1939-47. PubMed ID: 118803 [TBL] [Abstract][Full Text] [Related]
15. Comparative mammalian metabolism of adriamycin and daunorubicin. Loveless H; Arena E; Felsted RL; Bachur NR Cancer Res; 1978 Mar; 38(3):593-8. PubMed ID: 626965 [No Abstract] [Full Text] [Related]
16. [On the importance of thiamine redox transformations for thiamine fixation in tissue]. Dosta GA; OstrovskiÄ IuM Ukr Biokhim Zh; 1968; 40(5):464-8. PubMed ID: 5700767 [No Abstract] [Full Text] [Related]
17. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data. Ueda K; Kato Y; Komatsu K; Sugiyama Y J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics in blood IV: unusual distribution, storage effect and metabolism of methotrexate. Lee MG; Lui CY; Chen ML; Chiou WL Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):530-7. PubMed ID: 6511128 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of unconjugated bile acids on the enterohepatic circulation of methotrexate. Said HM; Strum WB; Hollander D J Pharmacol Exp Ther; 1984 Dec; 231(3):660-4. PubMed ID: 6502520 [TBL] [Abstract][Full Text] [Related]
20. [Experimental study on pharmacokinetics of methotrexate and its metabolite (7-hydroxy-methotrexate) in tissue]. Sasaki K; Hosoya R; Wang YM; Sutow WW; Fujimoto T Gan To Kagaku Ryoho; 1982 Oct; 9(10):1678-87. PubMed ID: 7184366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]